caffeic acid phenethyl ester has been researched along with curcumin in 17 studies
| Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (curcumin) | Trials (curcumin) | Recent Studies (post-2010) (curcumin) |
|---|---|---|---|---|---|
| 840 | 1 | 469 | 16,336 | 593 | 12,705 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, MR; Maruta, H | 1 |
| Burke, TR; Mazumder, A; Neamati, N; Pommier, Y; Sunder, S; Zhao, H | 1 |
| Farrow, S; Holloway, KA; Howells, L; Kaptein, A; Manson, MM; Munks, RJ; Plummer, SM | 1 |
| Calabrese, V; Foresti, R; Giuffrida Stella, AM; Green, CJ; Motterlini, R; Scapagnini, G | 1 |
| Alam, J; Balogun, E; Foresti, R; Gong, P; Green, CJ; Hoque, M; Killeen, E; Motterlini, R | 1 |
| Blijlevens, NM; de Witte, TJ; Donnelly, JP; M'Rabet, L; Marteijn, J; Timal, S; van't Land, B | 1 |
| Hitsuda, Y; Igishi, T; Kodani, M; Matsumoto, S; Nakanishi, H; Shigeoka, Y; Shimizu, E; Yasuda, K | 1 |
| Foresti, R; Green, CJ; Hoque, M; Monti, D; Motterlini, R | 1 |
| Nagasaka, R; Ohara, K; Ohshima, T; Uchida, A; Ushio, H | 1 |
| Calabrese, V; Caruso, C; Scapagnini, G | 1 |
| Chuu, CP; Kuo, LK; Lin, HP | 1 |
| Kim, SJ; Lee, ES; Nam, JH; Shin, DH; Zhang, Y | 1 |
| Choe, H; Choi, SW; Kim, KS; Kim, SJ; Kim, WK; Ko, TH; Shin, DH; Yoo, HY; Youm, JB; Zhang, YH | 1 |
| Chen, Q; Fu, W; Lei, Y; Ren, X; Wang, H; Yu, H | 1 |
| Musa, AE; Shabeeb, D | 1 |
| Khare, S; Khare, T; Palakurthi, S; Palakurthi, SS; Shah, BM | 1 |
| Manzanilla, B; Robles, J | 1 |
3 review(s) available for caffeic acid phenethyl ester and curcumin
| Article | Year |
|---|---|
From bench (laboratory) to bed (hospital/home): How to explore effective natural and synthetic PAK1-blockers/longevity-promoters for cancer therapy.
Topics: Animals; Antineoplastic Agents; Click Chemistry; Drug Discovery; Humans; Longevity; Neoplasms; p21-Activated Kinases; Protein Kinase Inhibitors | 2017 |
Radiation-Induced Heart Diseases: Protective Effects of Natural Products.
Topics: Biological Products; Caffeic Acids; Curcumin; Drug Combinations; Drugs, Chinese Herbal; Guaiacol; Heart Diseases; Hesperidin; Humans; Melatonin; Phenylethyl Alcohol; Protective Factors; Radiation Injuries; Selenium; Vitis | 2019 |
Natural Product-Based Nanomedicine in Treatment of Inflammatory Bowel Disease.
Topics: Animals; Benzoquinones; Biological Products; Biomimetics; Caffeic Acids; Curcumin; Cytokines; Exosomes; Humans; Inflammation; Inflammatory Bowel Diseases; Insecta; Macromolecular Substances; Nanomedicine; Oxidative Stress; Phenylethyl Alcohol; Phytochemicals; Plant Extracts; Polysaccharides; Quercetin; Resveratrol; Stilbenes; Transcription Factors; Translational Research, Biomedical; Vasoactive Intestinal Peptide; Zingiber officinale | 2020 |
14 other study(ies) available for caffeic acid phenethyl ester and curcumin
| Article | Year |
|---|---|
Arylamide inhibitors of HIV-1 integrase.
Topics: Caffeic Acids; Chromatography, High Pressure Liquid; Curcumin; Cytotoxins; Dose-Response Relationship, Drug; Enzyme Inhibitors; HIV Integrase; HIV Integrase Inhibitors; NF-kappa B; Phenylethyl Alcohol; Quinones; Structure-Activity Relationship | 1997 |
Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex.
Topics: Antineoplastic Agents; Caffeic Acids; Colonic Neoplasms; Curcumin; Cyclooxygenase 2; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; I-kappa B Kinase; I-kappa B Proteins; Isoenzymes; Membrane Proteins; NF-kappa B; NF-kappaB-Inducing Kinase; Phenylethyl Alcohol; Polyenes; Prostaglandin-Endoperoxide Synthases; Protein Serine-Threonine Kinases; Signal Transduction; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 1999 |
Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers.
Topics: Acetylcysteine; Animals; Astrocytes; Caffeic Acids; Cell Survival; Cells, Cultured; Curcumin; Drug Interactions; Enzyme Activation; Enzyme Induction; Glutathione; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Phenylethyl Alcohol; Rats; Up-Regulation | 2002 |
Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element.
Topics: Animals; Antioxidants; Blotting, Western; Caffeic Acids; Carrier Proteins; Curcumin; DNA-Binding Proteins; Electrophoretic Mobility Shift Assay; Gene Expression Regulation, Enzymologic; Heme Oxygenase (Decyclizing); LLC-PK1 Cells; NF-E2-Related Factor 2; Phenylethyl Alcohol; Promoter Regions, Genetic; Trans-Activators | 2003 |
Role of curcumin and the inhibition of NF-kappaB in the onset of chemotherapy-induced mucosal barrier injury.
Topics: Animals; Antineoplastic Agents; Caffeic Acids; Cell Line; Curcumin; Cytarabine; Drug Interactions; Female; Intestinal Mucosa; Methotrexate; NF-kappa B; Phenylethyl Alcohol; Rats; Rats, Inbred Strains | 2004 |
Sulindac sulfide and caffeic acid phenethyl ester suppress the motility of lung adenocarcinoma cells promoted by transforming growth factor-beta through Akt inhibition.
Topics: Adenocarcinoma; Antineoplastic Agents; Caffeic Acids; Catechin; Cell Movement; Curcumin; Humans; Lung Neoplasms; Neovascularization, Pathologic; NF-kappa B; Phenylethyl Alcohol; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Sulindac; Transforming Growth Factor beta; Tumor Cells, Cultured | 2004 |
Differential activation of heme oxygenase-1 by chalcones and rosolic acid in endothelial cells.
Topics: Animals; Aurintricarboxylic Acid; Caffeic Acids; Cattle; Cell Survival; Chalcone; Chalcones; Curcumin; Endothelial Cells; Enzyme Activation; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Mitogen-Activated Protein Kinases; Oxidative Stress; Phenylethyl Alcohol | 2005 |
The effects of hydroxycinnamic acid derivatives on adiponectin secretion.
Topics: 3T3-L1 Cells; Adipocytes; Adiponectin; Animals; Caffeic Acids; Coumaric Acids; Curcumin; Diabetes Mellitus, Type 2; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Interferon-gamma; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Phenylethyl Alcohol; Phenylpropionates; Phytotherapy; Pioglitazone; Plant Extracts; Plant Oils; Rice Bran Oil; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2009 |
Therapeutic potential of dietary polyphenols against brain ageing and neurodegenerative disorders.
Topics: Aging; Antioxidants; Brain; Caffeic Acids; Catechin; Curcumin; Diet; Flavonoids; Neurodegenerative Diseases; Neuroprotective Agents; Phenols; Phenylethyl Alcohol; Polyphenols | 2010 |
Combined treatment of curcumin and small molecule inhibitors suppresses proliferation of A549 and H1299 human non-small-cell lung cancer cells.
Topics: Antineoplastic Agents; Biological Availability; Caffeic Acids; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Chromones; Curcuma; Curcumin; Drug Therapy, Combination; Enzyme Inhibitors; ErbB Receptors; Humans; Morpholines; NF-kappa B; Phenylethyl Alcohol; Phosphoinositide-3 Kinase Inhibitors; Phytotherapy; Plant Extracts; Pyrimidines; Quinazolines; Receptors, Fibroblast Growth Factor; Signal Transduction; Somatomedins; Tyrphostins | 2012 |
Inhibition of Ca(2+) release-activated Ca(2+) channel (CRAC) by curcumin and caffeic acid phenethyl ester (CAPE) via electrophilic addition to a cysteine residue of Orai1.
Topics: Caffeic Acids; Calcium; Calcium Channels; Curcumin; Cysteine; HEK293 Cells; Humans; Mutation; ORAI1 Protein; Phenylethyl Alcohol | 2012 |
Class 3 inhibition of hERG K+ channel by caffeic acid phenethyl ester (CAPE) and curcumin.
Topics: Action Potentials; Caffeic Acids; Curcumin; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; HEK293 Cells; Humans; Kinetics; Phenylethyl Alcohol; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2013 |
Neuroprotective effect of three caffeic acid derivatives via ameliorate oxidative stress and enhance PKA/CREB signaling pathway.
Topics: Animals; Avoidance Learning; Caffeic Acids; Cell Survival; Curcumin; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Galactose; Hydrogen Peroxide; Lactates; Maze Learning; Mice; Neuroprotective Agents; Oxidative Stress; PC12 Cells; Phenylethyl Alcohol; Random Allocation; Rats; Signal Transduction; Spatial Memory | 2017 |
Antiradical properties of curcumin, caffeic acid phenethyl ester, and chicoric acid: a DFT study.
Topics: Caffeic Acids; Curcumin; Phenylethyl Alcohol; Succinates | 2022 |